Pharmacokinetic and analgesic properties of the injectable dosage form of a new imidazobenzimidazole derivative RU-1205 with kappa agonist activity

   
Spasov A.A.1, Smirnova L.A.1, Grechko O.U.2, Raschenko A.I.2 , Shtareva D.M.2, Anisimova V.A.3

1. Volgograd State Medical University, Volgograd, Russia; Volgograd Medical Research Center, Volgograd, Russia
2. Volgograd State Medical University, Volgograd, Russia
3. Institute of Physical and Organic Chemistry, South Federal University, Rostov-on-Don, Russia
Section: Experimental Study
DOI: 10.18097/PBMC20156105636      PubMed Id: 26539873
Year: 2015  Volume: 61  Issue: 5  Pages: 636-639
Pharmacokinetic properties of imidazobenzimidazole derivative compound RU-1205 were investigated after subcutaneous administration to rabbits as a substance and a dosage form (lyophilisates for injection) at a dose of 25 mg/kg. The lyophilisate was characterized by high values of the relative bioavailability. In tests, the “hot plate” and “vinegar cramps” the dosage form and the substance exhibited the same analgesic effect.
Download PDF:  
Keywords: pharmacokinetics, pharmacodinamics, analgesia, compound RU-1205, benzimidazols, injection dosage form
Citation:

Spasov, A. A., Smirnova, L. A., Grechko, O. U., Raschenko, A. I., Shtareva, D. M., Anisimova, V. A. (2015). Pharmacokinetic and analgesic properties of the injectable dosage form of a new imidazobenzimidazole derivative RU-1205 with kappa agonist activity. Biomeditsinskaya Khimiya, 61(5), 636-639.
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)